TDP-43 proteinopathies - From frontotemporal lobar degeneration to inclusion body myositis;Proteinopatie TDP-43 - Od zwyrodnienia czołowo-skroniowego do wtrętowego zapalenia mięoeni

Neurologia i Neurochirurgia Polska

Volumn 46, Issue 4, 2012, Pages 384-391

  Kierdaszuk, Biruta ^a   Berdyński, Mariusz ^b   Zekanowski, Cezary ^b   Kamińska, Anna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b CMDiK PAN w Warszawie   (Poland)

Author keywords

Amyotrophic lateral sclerosis; Frontotemporal lobar degeneration; Inclusion body myositis; TDP 43

Indexed keywords

PROGRANULIN; VALOSIN CONTAINING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CHROMOSOME 9P; FRONTOTEMPORAL DEMENTIA; GENE; GENE LOCUS; HUMAN; INCLUSION BODY MYOSITIS; REVIEW; TARDPB GENE; TDP 43 PROTEINOPATHY;

EID: 84866665659     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2012.30271     Document Type: Review

References (39)

1. Verma A., Tandan R. TDP-43: A reliable immunihistochemistry marker for inclusion body myositis? Muscle Nerve 2009; 40: 8-9.
2. Mercado P.A., Ayala Y.M., Romano M. i wsp. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 2005; 33: 6000-6010.
3. Wang I-F., Wu L-Sz., Shen C-K.J. TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol Med 2008; 14: 479-485.
4. Amador-Ortiz C., Lin W.L., Ahmed Z. i wsp. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007; 61: 435-445.
5. Uryu K., Nakashima-Yasuda H., Forman M.S. i wsp. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008; 67: 555-564.
6. Higashi S., Iseki E., Yamamoto R. i wsp. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007; 1184: 284-294.
7. Geser F., Winton M.J., Kwong L.K. i wsp. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008; 115: 133-145.
8. Fujishiro H., Uchikado H., Arai T. i wsp. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease. Acta Neuropathol 2009; 117: 151-158.
9. Neumann M., Sampathu D.M., Kwong L.K. i wsp. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
10. Neumann M., Kwong L.K., Lee E.B. i wsp. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic forms of TDP-43 proteinopathies. Acta Neuropathol 2009; 117: 137-149.
11. Salajegheh M., Pinkus J.L., Taylor J.P. i wsp. Sarcoplasmic redistribution of nuclear TDP-43 in incusion body myositis. Muscle Nerve 2009; 40: 19-31.
12. Morita M., Al-Chalabi A., Andersen P.M. i wsp. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006; 66: 839-844.
13. Weihl C.C., Pestronk A., Kimonis V.E. Valosin-containing protein disease: Incusion body myopathy with Paget's disease of the bone and fronto temporal dementia. Neuromuscul Disord 2009; 19: 308-315.
14. Pesiridis G.S., Lee V.M., Trojanowski J.Q. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet 2009; 18: R156-162.
15. Pinto S., Vlahovièek K., Buratti E. PRO-MINE: A bio-informatics repository and analytical tool for TARDBP mutations. Hum Mutat 2011; 32: E1948-1958.
16. Chen-Plotkin A.S., Xiao J., Geser F. i wsp. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration. Acta Neuropathol 2010; 119: 111-122.
17. Geser F., Martinez-Lage M., Kwong L.K. i wsp. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TCP-43 diseases. J Neurol 2009; 256: 1205-1214.
18. Zhang Y.J., Xu Y.F., Dickey C.A. i wsp. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 2007; 27: 10530-10534.
19. Kelley B.J., Haidar W., Boeve B.F. i wsp. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 2009; 30: 739-751.
20. Kirby J., Goodall E.F., Smith W. i wsp. Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. Neurogenetics 2010; 11: 217-225.
21. Gijselinck I., Van Broeckhoven C., Cruts M. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum Mutat 2008; 29: 1373-1386.
22. Masellis M., Momeni P., Meschino W. i wsp. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006; 129: 3115-3123.
23. Brouwers N., Sleegers K., Engelborghs S. i wsp. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 2008; 71: 656-664.
24. Rovelet-Lecrux A., Deramecourt V., Legallic S. i wsp. Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease. Neurobiol Dis 2008; 31: 41-45.
25. Rowland L.P., Mitsumoto H., Przedborski S. Amyotrophic lateral sclerosis, progressive muscular atrophy, and primary lateral sclerosis. W: Rowland L.P., Pedley T.A. [red.]. Merritt's Neu ro logy. 12 ed. Lippincott Williams & Wilkins, Philadelphia 2010, ss. 802-808.
26. Kuÿma-Kozakiewicz M., Kwieciñski H. The genetics of amyo-trophic lateral sclerosis. Neurol Neurochir Pol 2009; 43: 538-549.
27. Dickson D.W., Josephs K.A., Amador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 2007; 114: 71-79.
28. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: The FUS about TDP-43. Cell 2009; 136: 1001-1004.
29. Forman M.S., Trojanowski J.Q. M-Y Lee V. TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol 2007; 17: 548-555.
30. Corrado L., Ratti A., Gellera C. i wsp. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat 2009; 30: 688-694.
31. Benajiba L., Le Ber I., Camuzat A. i wsp. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009; 65: 470-473.
32. Borroni B., Bonvicini C., Alberici A. i wsp. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat 2009; 30: E974-983.
33. Weihl C.C., Temiz P., Miller S.E. i wsp. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008; 79: 1186-1189.
34. Olivé M., Janué A., Moreno D. i wsp. TAR DNA-Binding Protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol 2009; 68: 262-273.
35. Hernandez Lain A., Millecamps S., Dubourg O. i wsp. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: similarities in a TARDBP-linked ALS patients. J Neurol Neurosurg Psychiatry 2010; doi: 10.1136/jnmp.2010.208868.
36. Küsters B., Van Hoeve B.J.A., Schelhaas H.J. i wsp. TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol 2009; 117: 209-211.
37. Goebel H.H., Müller H.D. Protein aggregate myopathies. Semin Pediatr Neurol 2006; 13: 96-103.
38. Foulds P., McAuley E., Gibbons L. i wsp. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol 2008; 116: 141-146.
39. Kasai T., Tokuda T., Ishigami N. i wsp. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 2009; 117: 55-62.